Trial Profile
Double-blind, randomized, 3-period crossover study of suvorexant on electroencephalogram during sleep
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary) ; Zolpidem
- Indications Insomnia
- Focus Pharmacodynamics
- 14 Oct 2016 New trial record
- 20 Aug 2016 Results published in the European Neuropsychopharmacology